| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/15/2007 | WO2007017686A2 Tcr-v-beta related peptides for treatment and diagnosis of autoimmune disease |
| 02/15/2007 | WO2007017154A2 Human inhibitory anti-factor viii antibodies binding to the a2 domain |
| 02/15/2007 | WO2006129828A3 Target substance capturing molecule |
| 02/15/2007 | WO2006122797A3 Anti-gm-csf antibodies and uses therefor |
| 02/15/2007 | WO2006094724A3 Screening method, process for purifying of non-diffusible a-beta oligomers, selective antibodies against said non-diffusible a-beta oligomers and a process for manufacturing of said antibodies |
| 02/15/2007 | WO2006085967A3 OPTIMIZED ANTI-CD20 MONOCONAL ANTIBODIES HAVING Fc VARIANTS |
| 02/15/2007 | WO2006081139A3 Antibodies against interleukin-1 beta |
| 02/15/2007 | WO2005113059A3 Disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 02/15/2007 | WO2003099854A3 Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides |
| 02/15/2007 | US20070037967 conjugated by bridging molecules to proteins or polypeptides, reporter groups or cytotoxic agents; cancer |
| 02/15/2007 | US20070037965 Fusion proteins; human cytokine receptors; usefulness in both basic research and as therapeutics |
| 02/15/2007 | US20070037745 Nucleic acid and corresponding protein entitled 213P1F11 useful in treatment and detection of cancer |
| 02/15/2007 | US20070037741 Novel compositions and methods for the treatment of immune related disease |
| 02/15/2007 | US20070037255 Antibody variants with faster antigen association rates |
| 02/15/2007 | US20070037254 Expression Vectors and Methods |
| 02/15/2007 | US20070037233 Detection of Preharvest Sprouting in Cereal Grains |
| 02/15/2007 | US20070037230 Peptides for selectively and specifically binding Bacillus anthracis spores and use thereof in landscape phages |
| 02/15/2007 | US20070037222 Lineage restricted glial precursors |
| 02/15/2007 | US20070037218 Human gene critical to fertility |
| 02/15/2007 | US20070037217 Structure-based selection and affinity maturation of antibody library |
| 02/15/2007 | US20070037216 Dual expression vector system for antibody expression in bacterial and mammalian cells |
| 02/15/2007 | US20070037214 Generation and selection of protein library in silico |
| 02/15/2007 | US20070037203 Novel 21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, H1983, M1983, 38555 or 593 molecules and uses therefor |
| 02/15/2007 | US20070037193 Modulation of peroxisome proliferator-activated receptors |
| 02/15/2007 | US20070037191 Apo-2DcR |
| 02/15/2007 | US20070037147 Endogenous retrovirus polypeptides linked to oncogenic transformation |
| 02/15/2007 | US20070037145 drug screening; for carcinomas, especially lymphoma carcinomas |
| 02/15/2007 | US20070036818 Fabricated in baculovirus; for penetration into human erythrocytes in event of infection; vaccines against malaria |
| 02/15/2007 | US20070036813 Expression vector comprising nucleotide sequences coding endothelial growth factor protein for use in prevention and treatment of cell proliferative and eye disorders |
| 02/15/2007 | US20070036812 polypeptide with binding to antigen and is recognized by cytotoxic T lymphocytes; use as cancer vaccine |
| 02/15/2007 | US20070036809 Tolerance-induced targeted antibody production |
| 02/15/2007 | US20070036806 have an increased half-life, decreased immunogenicity, and reduce effector activity; diabetes, obesity, irritable bowel syndrome and other conditions that would be benefited by lowering plasma glucose, inhibiting gastric and/or intestinal motility and inhibiting gastric and/or intestinal emptying |
| 02/15/2007 | US20070036805 Comprising a specific binding agent which is an F(ab')2 or F(ab)2 antibody fragment that specifically binds a target toxin, and a second specific binding agent that comprises a small binding antibody fragment that binds the target toxin; Botulinum toxin |
| 02/15/2007 | US20070036799 Identification and engineering of antibodies with variant Fc regions and methods of using same |
| 02/15/2007 | US20070036798 Method and composition for reconforming multi-epitopic antigens to initiate an immune response |
| 02/15/2007 | US20070036796 For treating immunosuppressive diseases; AIDS |
| 02/15/2007 | US20070036795 Method of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular agonist |
| 02/15/2007 | US20070036794 Agonist anti-trkC monoclonal antibodies, directed against epitopes in extracellular domain of trkC receptor, which mimic biological activities of NT-3, the natural ligand of trkC receptor, but are free of some of known detriments of NT-3; use of theseagonist antibodies treatment of neuropathy |
| 02/15/2007 | US20070036792 Antibodies that specifically bind to Reg IV |
| 02/15/2007 | US20070036791 Interleukin-17 receptor homologue |
| 02/15/2007 | US20070036790 Treatment with anti-vegf antibodies |
| 02/15/2007 | US20070036789 Neutralizable Epitope of HGF and Neutralizing Antibody Binding to the Same |
| 02/15/2007 | US20070036788 Use of a compound for reducing the biological effectiveness of il-6 |
| 02/15/2007 | US20070036785 Pharmaceutical composition for treatment of diseases caused by IL-6 production |
| 02/15/2007 | US20070036784 Medicament for the protection against thrombotic diseases |
| 02/15/2007 | US20070036783 Antibody complexes |
| 02/15/2007 | US20070036782 Apo-2 ligand |
| 02/15/2007 | US20070036780 Modified proteins, designer toxins, and methods of making thereof |
| 02/15/2007 | US20070036778 Staphylococcus; immunogens; immumostimulatory sequences; cationic peptides |
| 02/15/2007 | US20070036755 Treatment with anti-vegf antibodies |
| 02/15/2007 | US20070036754 Treatment with anti-vegf antibodies |
| 02/15/2007 | US20070036753 Treatment with anti-vegf antibodies |
| 02/15/2007 | US20070036752 IL-2 fusion proteins with modulated selectivity |
| 02/15/2007 | US20070036751 Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies |
| 02/15/2007 | US20070036750 MCP1 fusions |
| 02/15/2007 | US20070036734 Therapeutic agent for periodontal disease |
| 02/15/2007 | US20070036719 antibodies and their use for detecting, imaging, staging, treating and monitoring of prostate cancer, and/or metastasis; prostate specific membrane antigen (PSMA) |
| 02/15/2007 | CA2619443A1 Glypican-3 (gpc3)-derived tumor rejection antigenic peptides useful for hla-a2-positive patients and pharmaceutical comprising the same |
| 02/15/2007 | CA2618796A1 Tcr-v-beta related peptides for treatment and diagnosis of autoimmune disease |
| 02/15/2007 | CA2616902A1 Human inhibitory anti-factor viii antibodies binding to the a2 domain |
| 02/15/2007 | CA2615776A1 Secretion of antibodies without signal peptides from bacteria |
| 02/15/2007 | CA2615460A1 Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility |
| 02/15/2007 | CA2615122A1 Immunoconjugate formulations |
| 02/15/2007 | CA2613482A1 Methods and compositions for diagnosis and treatment of influenza |
| 02/14/2007 | EP1752472A2 Chimeric amyloid beta peptides |
| 02/14/2007 | EP1752471A1 Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions |
| 02/14/2007 | EP1752465A2 Linear VH-CH1-VH-CH1 heavy chain antibody fragment |
| 02/14/2007 | EP1752163A1 Agent for actively restoring structure and functions of damaged tissues and organs |
| 02/14/2007 | EP1752160A2 Epitope sequences |
| 02/14/2007 | EP1751312A2 Polymorphism in tryptophan hydroxylase-2 controls brain serotonin synthesis |
| 02/14/2007 | EP1751282A2 Production of host cells containing mutiple integrating vectors by serial transduction |
| 02/14/2007 | EP1751192A1 Cross-linked antibodies |
| 02/14/2007 | EP1751191A2 Antibodies to angiogenesis inhibiting domains of cd148 |
| 02/14/2007 | EP1751190A2 Spore specific antibodies |
| 02/14/2007 | EP1751189A1 Diagnostic and therapeutic applications of soluble lhcgr protein |
| 02/14/2007 | EP1751187A2 Canine cd20 compositions |
| 02/14/2007 | EP1751181A1 BINDING MOIETIES BASED ON SHARK IgNAR DOMAINS |
| 02/14/2007 | EP1751178A2 Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with sars corona virus spike protein |
| 02/14/2007 | EP1750772A1 Phospholipase c gamma modulation and uses thereof for management of pain and nociception |
| 02/14/2007 | EP1750764A2 Antibodies of angiogenesis inhibiting domains of cd148 |
| 02/14/2007 | EP1750763A1 Method to reduce hepatotoxicity of fas-mediated apoptosis-inducing agents |
| 02/14/2007 | EP1750759A2 Screening method using antibody heavy chains |
| 02/14/2007 | EP1750720A2 Hepoxilins and modulators of ichthyin for treating skin disorders |
| 02/14/2007 | EP1417228B1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/14/2007 | EP1347048B1 Novel protease |
| 02/14/2007 | EP1283214B1 Novel collectins |
| 02/14/2007 | EP1206495B1 Chimeric polypeptides, method for production and uses thereof |
| 02/14/2007 | EP1124959B1 Cell surface molecule-induced macrophage activation |
| 02/14/2007 | EP1034268B1 G-protein coupled receptors and uses therefor |
| 02/14/2007 | EP1009726B1 Fluorination of proteins and peptides for f-18 positron emission tomography |
| 02/14/2007 | EP0975755B1 Crsp protein (cysteine-rich secreted proteins), nucleic acid molecules encoding them and uses therefor |
| 02/14/2007 | EP0770136B1 Method for selecting high-expressing host cells |
| 02/14/2007 | EP0662077B1 Cd27 ligand |
| 02/14/2007 | CN1914322A Cell expansion lethal toxin and detection of bacterium belonging to campylobacter genus that targets the same |
| 02/14/2007 | CN1914318A Method of obtaining gene tag |
| 02/14/2007 | CN1914227A Anti-MpI antibodies |
| 02/14/2007 | CN1914226A Antibodies against SARS-COV and methods of use thereof |
| 02/14/2007 | CN1913921A Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells |
| 02/14/2007 | CN1912119A Human HS5 AR-iso gene sequence, its coded protein and preparation method |
| 02/14/2007 | CN1912111A Engomphosis and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen |